Summary

According to this study, the global Cerebral Infarction Therapy market size will reach US$ million by 2030.
Cerebral infarction is a chronic and life-threatening disease.Cerebral infarction is one of the most important types of ischemic stroke in which blood enters the brain due to the development of blockages or clots in blood vessels.It is important to emphasize that cerebral infarction is different from cerebral hemorrhage.The chance of death is high because of the sudden onset of the disease.
This report presents a comprehensive overview, market shares, and growth opportunities of Cerebral Infarction Therapy market by product type, application, key players and key regions and countries.
Segmentation by product type:
Partial Anterior Circulation Infarct (PACI)
Total Anterior Circulation Infarct (TACI)
Posterior Circulation Infarct (POCI)
Segmentation by Application:
Hospital
Clinic
Medical Research Organization
This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Daiichi Sankyo
Johnson＆Johnson
Aprogen
Baxter
Otsuka
Mitsubishi Chemical Holdings Corporation
Nordmark
Takeda
Sanofi
Bristol-Myers Squibb
Kanion Pharmaceutical

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cerebral Infarction Therapy Market Size 2024-2030
2.1.2 Cerebral Infarction Therapy Market Size CAGR by Region
2.2 Cerebral Infarction Therapy Segment by Type
2.2.1 Partial Anterior Circulation Infarct (PACI)
2.2.2 Total Anterior Circulation Infarct (TACI)
2.2.3 Posterior Circulation Infarct (POCI)
2.3 Cerebral Infarction Therapy Market Size by Type
2.3.1 Global Cerebral Infarction Therapy Market Size Market Share by Type (2024-2030)
2.3.2 Global Cerebral Infarction Therapy Market Size Growth Rate by Type (2024-2030)
2.4 Cerebral Infarction Therapy Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Medical Research Organization
2.5 Cerebral Infarction Therapy Market Size by Application
2.5.1 Global Cerebral Infarction Therapy Market Size Market Share by Application (2024-2030)
2.5.2 Global Cerebral Infarction Therapy Market Size Growth Rate by Application (2024-2030)
3 Cerebral Infarction Therapy Key Players
3.1 Date of Key Players Enter into Cerebral Infarction Therapy
3.2 Key Players Cerebral Infarction Therapy Product Offered
3.3 Key Players Cerebral Infarction Therapy Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players Cerebral Infarction Therapy Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 Cerebral Infarction Therapy by Regions
4.1 Cerebral Infarction Therapy Market Size by Regions (2024-2030)
4.2 United States Cerebral Infarction Therapy Market Size Growth (2024-2030)
4.3 China Cerebral Infarction Therapy Market Size Growth (2024-2030)
4.4 Europe Cerebral Infarction Therapy Market Size Growth (2024-2030)
4.5 Rest of World Cerebral Infarction Therapy Market Size Growth (2024-2030)
5 United States
5.1 United States Cerebral Infarction Therapy Market Size by Type (2024-2030)
5.2 United States Cerebral Infarction Therapy Market Size by Application (2024-2030)
6 Europe
6.1 Europe Cerebral Infarction Therapy Market Size by Type (2024-2030)
6.2 Europe Cerebral Infarction Therapy Market Size by Application (2024-2030)
7 China
7.1 China Cerebral Infarction Therapy Market Size by Type (2024-2030)
7.2 China Cerebral Infarction Therapy Market Size by Application (2024-2030)
8 Rest of World
8.1 Rest of World Cerebral Infarction Therapy Market Size by Type (2024-2030)
8.2 Rest of World Cerebral Infarction Therapy Market Size by Application (2024-2030)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Key Investors in Cerebral Infarction Therapy
10.1 Company A
10.1.1 Company A Company Details
10.1.2 Company Description
10.1.3 Companies Invested by Company A
10.1.4 Company A Key Development and Market Layout
10.2 Company B
10.2.1 Company B Company Details
10.2.2 Company Description
10.2.3 Companies Invested by Company B
10.2.4 Company B Key Development and Market Layout
10.3 Company C
10.3.1 Company C Company Details
10.3.2 Company Description
10.3.3 Companies Invested by Company C
10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……
11 Key Players Analysis
11.1 Daiichi Sankyo
11.1.1 Daiichi Sankyo Company Details
11.1.2 Daiichi Sankyo Cerebral Infarction Therapy Product Offered
11.1.3 Daiichi Sankyo Cerebral Infarction Therapy Market Size (2024 VS 2030)
11.1.4 Daiichi Sankyo Main Business Overview
11.1.5 Daiichi Sankyo News
11.2 Johnson＆Johnson
11.2.1 Johnson＆Johnson Company Details
11.2.2 Johnson＆Johnson Cerebral Infarction Therapy Product Offered
11.2.3 Johnson＆Johnson Cerebral Infarction Therapy Market Size (2024 VS 2030)
11.2.4 Johnson＆Johnson Main Business Overview
11.2.5 Johnson＆Johnson News
11.3 Aprogen
11.3.1 Aprogen Company Details
11.3.2 Aprogen Cerebral Infarction Therapy Product Offered
11.3.3 Aprogen Cerebral Infarction Therapy Market Size (2024 VS 2030)
11.3.4 Aprogen Main Business Overview
11.3.5 Aprogen News
11.4 Baxter
11.4.1 Baxter Company Details
11.4.2 Baxter Cerebral Infarction Therapy Product Offered
11.4.3 Baxter Cerebral Infarction Therapy Market Size (2024 VS 2030)
11.4.4 Baxter Main Business Overview
11.4.5 Baxter News
11.5 Otsuka
11.5.1 Otsuka Company Details
11.5.2 Otsuka Cerebral Infarction Therapy Product Offered
11.5.3 Otsuka Cerebral Infarction Therapy Market Size (2024 VS 2030)
11.5.4 Otsuka Main Business Overview
11.5.5 Otsuka News
11.6 Mitsubishi Chemical Holdings Corporation
11.6.1 Mitsubishi Chemical Holdings Corporation Company Details
11.6.2 Mitsubishi Chemical Holdings Corporation Cerebral Infarction Therapy Product Offered
11.6.3 Mitsubishi Chemical Holdings Corporation Cerebral Infarction Therapy Market Size (2024 VS 2030)
11.6.4 Mitsubishi Chemical Holdings Corporation Main Business Overview
11.6.5 Mitsubishi Chemical Holdings Corporation News
11.7 Nordmark
11.7.1 Nordmark Company Details
11.7.2 Nordmark Cerebral Infarction Therapy Product Offered
11.7.3 Nordmark Cerebral Infarction Therapy Market Size (2024 VS 2030)
11.7.4 Nordmark Main Business Overview
11.7.5 Nordmark News
11.8 Takeda
11.8.1 Takeda Company Details
11.8.2 Takeda Cerebral Infarction Therapy Product Offered
11.8.3 Takeda Cerebral Infarction Therapy Market Size (2024 VS 2030)
11.8.4 Takeda Main Business Overview
11.8.5 Takeda News
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Cerebral Infarction Therapy Product Offered
11.9.3 Sanofi Cerebral Infarction Therapy Market Size (2024 VS 2030)
11.9.4 Sanofi Main Business Overview
11.9.5 Sanofi News
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Details
11.10.2 Bristol-Myers Squibb Cerebral Infarction Therapy Product Offered
11.10.3 Bristol-Myers Squibb Cerebral Infarction Therapy Market Size (2024 VS 2030)
11.10.4 Bristol-Myers Squibb Main Business Overview
11.10.5 Bristol-Myers Squibb News
11.11 Kanion Pharmaceutical
12 Research Findings and Conclusion